(Q27852071)

English

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer (English)
0 references
Sara A Hurvitz
0 references
Luc Dirix
0 references
Judit Kocsis
0 references
Giulia V Bianchi
0 references
Janice Lu
0 references
Jeferson Vinholes
0 references
Ellie Guardino
0 references
Chunyan Song
0 references
Barbara Tong
0 references
Vivian Ng
0 references
Yu-Waye Chu
0 references
20 March 2013
0 references
31
0 references
9
0 references
1157-63
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit